home.aspx
 
EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

Alina Combine Pharmaceuticals Pvt. Ltd.

Alina Combine Pharmaceuticals (Pvt) Ltd is one of Pakistan's premier Pharmaceutical & Veterinary Medicine manufacturing company following strict GMP guidelines. Our pharmaceutical manufacturing unit is well equipped and manned by highly qualified and experienced personnel. Our current range of products includes Water Soluble Powders, Liquids/Solutions, Liquid Injections in the Veterinary Department and a range of Human Pharmaceuticals in the form of Liquids, Tablets, Ointments, and Injections.

RELATED NEWS


Scott Gottlieb and Pfizer surely knew critics would challenge the former FDA commissioner’s decision to join the pharma giant's board-less than three months after his departure from the agency, no less. And at least one high-profile lawmaker is doing just that, as Sen. Elizabeth Warren called on Gottlieb to reconsider. The move smacks of corruption, Warren wrote in a letter following the announcement. Gottlieb will join a company that has billions of dollars at stake in the decisions m...
FIERCEPHARMA
READ MORE

Aberdeen announced Aberdeen Behavioral Technographics – the industry’s first install (technographic) data that actively measures technology in use. Legacy technographic data only provides a single yes/no estimate as to whether a company uses a specific technology. Aberdeen Behavioral Technographics is the first to measure technology usage down to company location, number of users and pains and priorities of the usage. In numerous tests, Aberdeen Behavioral Technographics has proven t...

READ MORE

Baloxavir marboxil, a flu drug seen by Roche as a successor to Tamiflu, significantly sped time to relief for patients highly vulnerable to serious complications. The Swiss firm said that if the single dose oral drug is approved, it could be the first new method of treating flu for two decades. Roche is planning filings with regulators after the phase 3 CAPSTONE-2 trial showed baloxavir marboxil significantly reduced the time to the improvement of flu symptoms compared with placebo....

READ MORE

Amid the political chaos and bitter recriminations in Westminster in the build-up to Brexit, there is still a risk of delays to health and social care supplies if the UK leaves the EU without a deal, the UK’s National Audit Office (NAO) has warned. An independent Parliamentary body, the NAO audits central government departments, government agencies, and non-departmental public bodies as well as assessing value for money audits of public policy. In a report published today the NAO reviewed ...

READ MORE

UK-based GW Pharmaceuticals surged ahead on the stock market after it announced its cannabis-based drug Epidiolex had succeeded in a phase 3 trial that could lead to a new use. The company’s Q1 results, announced at the same time, show that Epidiolex (cannabidiol) is gaining traction in the US market, where it has been approved for the rare forms of childhood epilepsy Lennox-Gastaut syndrome and Dravet Syndrome since last summer. GW is also hoping for approval in tuberous sclerosis complex...

READ MORE

With Amgen’s competing bone drug now sidelined, Radius has a big opportunity ahead with its Tymlos launch. And the company is staffing up accordingly. Monday, the Massachusetts biotech said it had brought on Jesper Høiland, former president of Novo Nordisk’s U.S. business, as its new CEO. He’ll replace Bob Ward, who guided the company though its IPO and Tymlos’ journey to approval, which concluded with an FDA nod in late April. Radius’ board "thought long and hard about making sure we have the r...

READ MORE

EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...